Sandoz & Anr v Bristol-Myers Squibb & Ors [2022] EWHC 1831 (Pat)15 July 2022Andrew Lykiardopoulos QC appeared for Sandoz and Justin Turner QC appeared for Teva  in proceedings to invalidate 4 patents owned by Bristol-Myers Squibb (“BMS”) and Pfizer, both of whom counterclaimed that the generic products which Sandoz and Teva intended to launch on the UK market would infringe. The patents related to a formulation of apixaban […]
Neurim Pharmaceuticals (1991) Ltd & Anr v Teva UK Ltd [2022] EWHC 1641 (Pat)29 June 2022Charlotte May QC and Henry Ward successfully appeared for the defendant (“Teva”) in a second application brought by the claimants (“Neurim”) for interim injunctive relief, the first application (also successfully defended by Charlotte May QC) having been rejected by Mellor J on 14 April 2022.  The underlying claim related to infringement of Neurim’s patent for […]
Alcon Research v Pharmathen [2022] EWCA Civ 84528 June 2022Lindsay Lane KC and William Duncan appeared for the second defendant (“Aspire”) in an appeal of the judgment of Meade J finding that a patent for the use of fluprostenol isopropyl ester (“FIE”), a prostaglandin F2α (“PGF2α”) analogue, also known as travoprost, for the treatment of glaucoma and ocular hypertension was valid and infringed.  The […]
Shazam v Only Fools The Dining Experience [2022] EWHC 1379 (IPEC)8 June 2022Shazam, the company holding the rights in the sitcom Only Fools and Horses previously owned by its creator, John Sullivan, sued Only Fools The Dining Experience (‘OFDE’) and related companies and individuals for using characters, catchphrases, themes and other material taken from the sitcom in their immersive theatrical dining experience “Only Fools The (cushty) Dining […]
Advanced Bionics AG & Anr v Med-El Elektromedizinische Geräte Gmbh [2022] EWHC 1345 (Pat)1 June 2022Andrew Lykiardopoulos QC appeared as lead counsel for the claimants (“Advanced Bionics”) in proceedings brought against the defendant (“Med-El”) to revoke a patent relating to MRI-safe disk magnets and/or a declaration that Advanced Bionics’ implant device did not infringe.  Med-El counterclaimed for infringement, with the proceedings conducted through the Shorter Trials Scheme. The trial in […]